Showing 1991-2000 of 5643 results for "".
- SightGlass Vision to Present Pivotal Clinical Trial Baseline Data Evaluating Novel Lenses to Control Nearsightedness in Childrenhttps://modernod.com/news/sightglass-vision-to-present-pivotal-clinical-trial-baseline-data-evaluating-novel-lenses-to-control-nearsightedness-in-children/2476876/SightGlass Vision announced that baseline data from CYPRESS, the company’s pivotal trial assessing the safety and efficacy of novel lenses designed to control nearsightedness in children, will be presented at the 17th International Myopia Conference 2019, held
- Macular Degeneration Conference Series in the Spotlighthttps://modernod.com/news/macular-degeneration-conference-series-in-the-spotlight/2476865/Part of the 2019 Macular Degeneration Association Educational Conference Series will take place on Saturday, September 21, at the Doubletree Chicago North Shore Conference Center Skokie, Illinois. The conference, “Eyes on Sight,” is aimed to deliver the most up-to-date research regarding t
- NHS England to Fund Novartis’ Gene Therapy Luxturna for Inherited Retinal Diseasehttps://modernod.com/news/nhs-england-to-fund-novartis-gene-therapy-luxturna-for-inherited-retinal-disease/2476855/NHS England announced Wednesday funding for Novartis’ Luxturna (voretigene neparvovec) after agreeing a deal with the company that will provide access to the gene therapy from January 2020. The one-time treatment gained European Commission approval last year for patients with vision loss du
- Now Optics Names Two Women to its Executive Leadership Teamhttps://modernod.com/news/now-optics-names-two-women-to-its-executive-leadership-team/2476834/Now Optics recently named two women to its leadership team. Former CVS Health’s Morgan Diaz joined Now Optics as senior vice president of operations and business development, and Lukana Justin previously from Office Depot Inc. is the new, senior vice president of marketing. They join Tara Pellegr
- Iconic Therapeutics Signs Ophthalmology Option Agreement With Novartishttps://modernod.com/news/iconic-therapeutics-signs-ophthalmology-option-agreement-with-novartis/2476818/Iconic Therapeutics announced that the company has signed an agreement with Novartis in which Novartis will have an option on Iconic’s ophthalmology program, now in preclinical development. Novartis made an upfront payment and an equity investment in Iconic. The details of investment were not dis
- Doctor Alexa Will See You Now: Is Amazon Primed To Come To Your Rescue?https://modernod.com/news/doctor-alexa-will-see-you-now-is-amazon-primed-to-come-to-your-rescue/2476782/Now that it’s upending the way you play music, cook, shop, hear the news and check the weather, the friendly voice emanating from your Amazon Alexa-enabled smart speaker is poised to wriggle its way into all things health care. Amazon has big ambitions for its devices, according to a
- Now Optics Launches New Advertising Campaign ‘The Perfect Fit’https://modernod.com/news/now-optics-launches-new-advertising-campaign-the-perfect-fit/2476780/Now Optics, which provides eyewear under the retail brands Stanton Optical and My Eyelab, has announced a new advertising campaign, ‘The Perfect Fit.’ Developed in conjunction with its agency, Barkley, ‘The Perfect Fit’ highlights walk-in eye exam appointments, eyeglasses and eyewear assor
- Notal Vision Diagnostic Clinic Reports Completion of 6 Million ForeseeHome AMD Home-Monitoring Testshttps://modernod.com/news/notal-vision-diagnostic-clinic-reports-completion-of-6-million-foreseehome-amd-home-monitoring-tests/2476750/Notal Vision announced the completion of 6 million patient tests performed with ForeseeHome, the first FDA-cleared home-monitoring device for patients with intermediate dry age-related macular degeneration (AMD) at risk for developing wet AMD, according to a company news release. ForeseeHo
- SIFI Announces Expansion in the French Market With Acquisition of Dacudoses and Novoptinehttps://modernod.com/news/sifi-announces-expansion-in-the-french-market-with-acquisition-of-dacudoses-and-novoptine/2479574/Italian ophthalmic company SIFI has announced the acquisition of Dacudoses and Novoptine antiseptic brands in France from Laboratoire Gifrer Barbezat. Terms of the deal were not disclosed. Dacudoses is the leading reimbursed RX brand of the French ophthalmic antiseptic segment, pres
- Hoya Surgical Optics Obtains CE Mark for Nanex multiSert+ IOL Delivery Systemhttps://modernod.com/news/hoya-surgical-optics-obtained-ce-mark-for-nanex-multisert-iol-delivery-system/2476708/Hoya Surgical Optics has obtained CE Mark for Nanex multiSert+, which consists of a a new IOL delivered in a first-of-its kind preloaded delivery system, according to a company news release. The 1.62 mm injector tip of multiSert+ is the world’s smallest nozzle size in